Indonesia IVD Market Research, Industry Trends, Market Share


Published: 07/19/2017
Pages: 217
Full Study Price: US$ 4,200

With a current population of over 260 million, Indonesia is an important and prospective market for manufacturers of diagnostics and medical devices. Indonesia IVD Market Analysis was produced by industry analysts operating in Malaysia and Indonesia, and covers the Indonesian markets for life science and clinical applications of in vitro diagnostics (IVD) technology, and provides in-depth expert discussion on healthcare, regulatory trends, and the competitors currently operating in this market.

Indonesia IVD Market Analysis covers Indonesia’s market for in vitro diagnostics technology market, which currently faces certain challenges. However, Indonesia’s healthcare sector is set to experience rapid growth in the next five years, due to various initiatives by its government. Most importantly among these government initiatives is the universal health coverage (UHC) plan, locally known in Indonesia as JKN, which was announced in 2014. Under the UHC, the Indonesian government is undertaking the task to ensure that health insurance coverage is made available to the entire national population by 2019.

Our Simple Buying Process

Choose License and Add
This Report To Your Cart.

Register, Checkout
and Verify Payment.

Receive Notification When
Your Report Is Available.

Table Of Contents

  • Executive Summary
    • Introduction
      • Table Map of Indonesia, with Provinces
      • Table Total Population of Indonesia (2000-2016)
      • Table GDP Growth in Indonesia, 2012-2015
    • Health Status of Indonesians
    • Healthcare Delivery System
    • Regulation of IVD Devices and Distribution
    • Scope and Methodology
    • Size and Growth of the IVD Market
      • Table IVD Market in Indonesia, 2017 and 2022
  • Indonesia - A Growing IVD Market
    • Healthcare Expenditure
      • Table Growth of Health Expenditure per Capita (USD) in Indonesia, 2000-2014
      • Table Growth of Health Expenditure per Capita in PPP Terms (USD), Indonesia, 2000-2014
    • Health Indicators
      • Table Top 10 Causes of Death in Indonesia
      • Table Life Expectancy and Mortality Rates in Indonesia, 2000-2014
    • Prevalent Infectious Diseases in Indonesia
      • Tuberculosis (TB)
        • Table Assessment of TB Burden in Indonesia, WHO*
        • Table Pulmonary Tuberculosis Cases by Province, Indonesia* All Cases
      • HIV/AIDS
        • Table The Number of New Cases of HIV and AIDS between 2011 and 2015, Indonesia
        • Table HIV and AIDS Cases in Indonesia, by Province
      • Malaria
        • Table Incidence of Malaria in Indonesia, by Province
      • Dengue
        • Table Dengue Hemorrhagic Fever (DHF) Cases in Indonesia, by Province*
      • Filariasis
        • Table Filariasis in Indonesia, 2011-2015
        • Table Filariasis Cases in Indonesia, by Province, 2012-2014
      • Leptospirosis
        • Table Leptospirosis Cases in Indonesia, by Province, 2011-2015
      • Typhoid
        • Table Typhoid Prevalence in Indonesia, by Province*
      • Human Papilloma Virus (HPV)
    • Indonesian Healthcare Industry Landscape
      • Table Healthcare Delivery in Indonesia
      • Healthcare Delivery System
      • Public Healthcare System: General and Specialty Hospitals
        • Table General and Specialty Hospitals in Indonesia, 2011-2015
      • Public Healthcare System: Community Healthcare Centers (CHCs/Puskesmas)
        • Table Community Healthcare Centers in Indonesia, 2011-2015
        • Table Distribution of Puskesmas (CHCs) in Indonesia across 34 Provinces
      • Hospital Classification in Indonesia
        • Table Selected General and Specialty Hospitals in Indonesia*
      • Private Healthcare System
        • Table Selected Leading Private Hospitals in Indonesia, by Province
      • Private Labs in Indonesia
        • Table Selected Private Laboratories in Indonesia
    • Financial Aspects of the Healthcare Industry in Indonesia
      • Table Indonesia Healthcare Spending Compared to Southeast Asia Neighbors
      • Table Indonesia Healthcare Expenditure, 2000-2014
      • Implementation of UHC
      • Private Health Insurance
    • E-Catalogue Pricing System
    • Key Market Drivers of the Indonesian Healthcare Market
    • Key Challenges in the Indonesian Healthcare Market
      • Uncertainty among Private Insurers
      • Rigid Reference Model Hampering Healthcare Accessibility
      • Limited Access to Quality Healthcare Facilities
      • Gap between Supply and Demand of Medical Professionals
      • Impact of the E-Catalogue Pricing System
      • Impact of Government's Policies on Foreign Direct Investments (FDI)
      • Logistics Challenges
    • IVD Product Regulation in Indonesia
      • Table Classification of Medical Devices
    • Important Factors to Consider While Choosing an IVD Distributor in Indonesia
      • Trade-Off between Small and Big Distributors
        • Table Selected Foreign Companies and Their Key Distributors in Indonesia
    • Processes for Distribution License, Company and Product Registrations
      • Company/Product Registration
        • Table Licenses Required for IVD Distribution in Indonesia
    • Regulatory Trends and Insights Relevant for the IVD Sector
      • Market Transition to E-Catalogue and Related Regulations
    • Regulations for Foreign Direct Investments (FDI)
      • Table Indonesia Investment Coordinating Board (BKPM) Offices
    • Setting Up a Company in Indonesia
      • Table Options for a Foreign IVD Company to Enter the Indonesian Market
      • Assessing Option 1: Opening an Affiliated Branch Office in Indonesia
      • Assessing Option 2: Select a Suitable Exclusive Distributor
      • Assessing Option 3: Set up OEM Operations; Invest in Local Manufacturing within 3 years
    • Business Strategies Adopted by Multinational Companies (MNCs): Case Studies
      • Roche
      • bioMerieux
      • Thermo Fisher Scientific
      • Conclusion
  • IVD Market Analysis
    • Microbiology
      • LFIA Tests (Rapid Tests) for Infectious Diseases
        • Table Sales of Rapid Tests for Infectious Diseases by Category, Indonesia, 2017-2022 ($, Million)
        • Table Popular Rapid Test Brands and Their Distributors in Indonesia
      • Lab-based Immunoassays for Infectious Diseases
        • Table STD Test Costs at Selected Clinics and Hospitals in Indonesia
        • Table Major Diseases and Demand for Lab-based Immunoassay Diagnostics in Indonesia, 2017-2022 ($, Million)
      • ID/AST
      • Molecular Diagnostics
        • Table Microbiology Sales in Indonesia, 2017-2022 ($, Million)
    • Hematology
      • Table List of Major Players in the Indonesian Hematology Market
      • Table Hematology Sales by Category, Indonesia, 2017-2022 ($, Million)
    • Clinical Chemistry
      • Table List of Major Players in the Indonesian Clinical Chemistry Market
      • Table Clinical Chemistry Analyzer Sales by Category, Indonesia, 2017-2022 ($, Million)
    • Point-of-Care Tests
      • POC - OTC/ Self-Testing
      • POC – Professional-Testing
      • POC Hand-Held Devices
      • POC Bench-Top Analyzers
        • Table POC Sales by Category, Indonesia, 2017-2022 ($, Million)
    • Immunoassays
      • Point-of-Care (POC) Immunoassays
      • Immunoassays for Non-Infectious Diseases
        • Table Immunoassay (Non-Infectious) Sales by Category, Indonesia, 2017-2022 ($, Million)
    • Blood Testing and Typing
      • Table Distribution of Blood Centers in Indonesia, by Province*
      • Non-Standardized Evaluation Protocol
        • Table Blood Testing and Typing Sales by Category (ABO Grouping, Immunoassays [ELISA and Rapid Tests], NAT), Indonesia, 2017-2022 ($, Million)
    • Urinalysis
      • Table List of Major Players in the Indonesian Urinalysis Market
    • Coagulation
      • Table List of Major Players in the Indonesian Coagulation Market
      • Table Hemostasis Sales by Category (Lab-based Coagulation Tests, POC Coagulation Tests), Indonesia, 2017-2022 ($, Million)
    • Histology
      • Table List of Major Players in the Indonesian Histology Market
      • Table Histology Sales by Category (Traditional Non-Pap Stains, Pap Tests, HPV, Other [includes ISH, IHC, Digital Imaging, CTC, and Flow Cytometry]), Indonesia, 2017-2022 ($, Million)
    • Total IVD Markets in Indonesia
      • Table Total IVD Market in Indonesia by Segment (Microbiology, Hematology, Clinical Chemistry, POC, Immunoassays - Non-Infectious Diseases, Blood Testing and Typing, Urinalysis, Coagulation, Histology, Others [includes Molecular Diagnostics (Non-Infectious), Supplies, Reagents, IT, Imaging, Automation, etc.]), 2017-2022 ($ Millions)
  • IVD Companies, Private Labs and Distributor Profiles
    • IVD Company Profiles
      • Abbott Laboratories
      • Alere
      • Arkray Healthcare
      • Beckman Coulter
      • Becton, Dickinson and Company (BD)
      • bioMerieux
      • Bio-Rad
      • Cellavision
      • Cepheid
      • Critical Diagnostics
      • DiaSorin S.p.A.
      • EKF Diagnostics
      • ERBA Diagnostics
      • HemoCue AB
      • Hologic, Inc.
      • Horiba, Ltd.
      • Instrumentation Laboratory Company
      • Luminex Corporation
      • Mindray Medical International Limited
      • Nihon Kohden Corporation
      • Ortho Clinical Diagnostics
      • Qiagen N.V.
      • Radiometer Medical ApS
      • Randox Laboratories
      • Roche Diagnostics
      • Siemens Healthineers
      • Sysmex Corporation
      • Thermo Fisher Scientific
      • Tosoh Corporation
      • Trinity Biotech
    • Leading Private Labs in Indonesia
      • Laboratorium Klinik Utama Bio Medika
      • PT Cito Putra Utama
      • PT Kimia Farma Diagnostika
      • Laboratorium Klinik Pramita
      • PT Prodia Widyahusada Tbk
    • Profiles of Selected IVD Distributors in Indonesia
      • Table Profiles of Selected IVD Distributors in Indonesia
  • Glossary
    • Table Glossary